Circulating Tumor Cell Count Can Be a Useful Prognostic Factor in Lung Resection via Cardiopulmonary Bypass
Tumor resection with cardiopulmonary bypass (CPB) remains controversial in the field of oncology. Here, we present a 57-year-old male patient with locally advanced squamous cell carcinoma. The tumor was located in the left hilum and invaded the left atrium. Complete resection, left pneumonectomy com...
Main Authors: | Masaki Hashimoto, Yoshitomo Okumura, Fumihiro Tanaka, Kazue Yoneda, Teruhisa Takuwa, Nobuyuki Kondo, Seiki Hasegawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2017-02-01
|
Series: | Case Reports in Oncology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/457116 |
Similar Items
-
Development of cardiopulmonary bypass: A historical review
by: Šušak Stamenko, et al.
Published: (2016-01-01) -
Ultrafiltration Technology and Its Application in Cardiopulmonary Bypass
by: Zhang Kun, et al.
Published: (2017-01-01) -
Evaluation of Inflammation Caused by Cardiopulmonary Bypass in a Small Animal Model
by: Yutaka Fujii
Published: (2020-04-01) -
Myocardial damage in cardioplegia and cardiopulmonary bypass
by: M.Т. Vatutin, et al.
Published: (2016-05-01) -
Comparison of blood electrolytes and glucose during cardiopulmonary bypass in diabetic and non-diabetic patients
by: Golamreza Maasoumi, et al.
Published: (2013-01-01)